Streetbeat News

Price Targets

AURA

BTIG analyst Robert Hazlett has maintained a Buy rating on Aura Biosciences (NASDAQ:AURA) but has reduced the price target from $38 to $21.

Portfolio Pulse from Benzinga Newsdesk

December 08, 2023 | 5:43 pm

HCP

BTIG analyst Gray Powell has maintained a Buy rating on HashiCorp (NASDAQ:HCP) but has reduced the price target from $33 to $25.

Portfolio Pulse from Benzinga Newsdesk

December 08, 2023 | 5:42 pm

CDMO

RBC Capital analyst Sean Dodge has maintained an Outperform rating on Avid Bioservices (NASDAQ:CDMO) but has reduced the price target from $15 to $7.

Portfolio Pulse from Benzinga Newsdesk

December 08, 2023 | 5:36 pm

CHWY

Chewy Inc (CHWY) reported Q3 2023 results with revenue of $2.74 billion, missing estimates by $0.02 billion, but EPS of 15 cents beat the six-cent loss expected. Analysts from Needham, RBC Capital, Piper Sandler, and Morgan Stanley have expressed concerns over top-line challenges and adjusted their price targets accordingly. The company's stock price declined by 2% in aftermarket trading. Management is prepared for a potential demand moderation in FY24 and has already cut 8% of corporate employees. Analysts are looking forward to the company's investor day for insights on long-term strategies.

Portfolio Pulse from Anusuya Lahiri

December 08, 2023 | 5:35 pm

GMS

RBC Capital analyst Mike Dahl has maintained a 'Sector Perform' rating on GMS Inc. (NYSE:GMS) and increased the price target from $68 to $70.

Portfolio Pulse from Benzinga Newsdesk

December 08, 2023 | 5:34 pm

BDC

Truist Securities analyst William Stein has reaffirmed a Buy rating on Belden (NYSE:BDC) and increased the price target from $75 to $79.

Portfolio Pulse from Benzinga Newsdesk

December 08, 2023 | 5:30 pm

AVGO

Truist Securities analyst William Stein has reaffirmed a Buy rating on Broadcom (NASDAQ:AVGO) and increased the price target from $995 to $1015.

Portfolio Pulse from Benzinga Newsdesk

December 08, 2023 | 5:27 pm

CNM

Truist Securities analyst Keith Hughes has maintained a Hold rating on Core & Main (NYSE:CNM) and increased the price target from $30 to $38.

Portfolio Pulse from Benzinga Newsdesk

December 08, 2023 | 5:25 pm

RH

B of A Securities analyst Curtis Nagle has maintained a Buy rating on RH (NYSE:RH) but has reduced the price target from $345 to $309.

Portfolio Pulse from Benzinga Newsdesk

December 08, 2023 | 5:23 pm

BMEA

Citigroup analyst Yigal Nochomovitz has reiterated a Buy rating on Biomea Fusion (NASDAQ:BMEA) and maintained a $90 price target for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

December 08, 2023 | 5:17 pm